Conversion
Important — Diabetes & Metabolic Conditions
This article discusses thyroid hormone conversion, carbohydrate signaling, and dietary patterns. If you have diabetes, insulin resistance, metabolic syndrome, or any condition requiring medication management of blood sugar, do not make dietary changes based on this content without direct guidance from your prescribing physician. Blood sugar responses to dietary change are individual and can be dangerous without supervision. This is educational content — not a treatment protocol and not a prescription.
Most people with thyroid symptoms have been told their thyroid is fine. Their TSH came back in the normal range. Maybe their T4 too. And yet they are cold when no one else is cold, losing hair in the shower, unable to lose weight no matter what they restrict, exhausted by noon, and being told it might be depression.
The thyroid gland is producing hormone. That hormone is not becoming the active form that runs metabolism. These are two different problems — and the standard thyroid test measures only one of them.
T4 Is the Storage Form. T3 Is the Active Form.
The thyroid gland produces mostly T4 — thyroxine. T4 is a transport hormone. It circulates in the bloodstream, but it cannot enter cells and drive metabolic activity on its own. Before T4 can do anything useful, it must be converted to T3 — triiodothyronine — the active form that actually enters cells, activates mitochondria, drives thermogenesis, governs serotonin synthesis, and regulates every system in the body that depends on metabolic rate.
The enzyme responsible for this conversion is a deiodinase — specifically type 1 deiodinase (D1) and type 2 deiodinase (D2). These enzymes remove one iodine atom from T4, converting it to T3. This conversion happens primarily in the liver — which accounts for 60% or more of total T3 production in the body. The remainder occurs in the kidneys, gut, muscle, and peripheral tissues.
Why this matters: the thyroid is upstream of the problem
A person can have a perfectly functioning thyroid gland — producing normal amounts of T4 — and still be clinically hypothyroid if the conversion step is impaired. Their thyroid gland is working. Their TSH will look normal. Their T4 will look normal. But the T4 is not becoming T3 — and without T3, the cells cannot do their jobs. The standard thyroid test measures the signal (TSH) and the storage hormone (T4). It does not measure the conversion or the active form. It cannot detect this failure.
TSH (thyroid-stimulating hormone) is produced by the pituitary and tells the thyroid gland to make more T4. A normal TSH means the pituitary is satisfied with T4 levels in circulation. It says nothing about whether T4 is being converted to T3 in the liver and peripheral tissues.
Conversion failure in the liver. Reverse T3 blocking the receptor. Selenium or iron deficiency impairing the deiodinase enzyme. Inflammation suppressing conversion. Elevated cortisol diverting T4 away from the T3 pathway. None of these move the TSH needle.
TSH and Fasting Glucose — The Same Diagnostic Failure
The thyroid testing problem has an almost exact parallel in metabolic medicine. Fasting glucose is used to assess blood sugar regulation — but fasting glucose is the last marker to become abnormal. By the time fasting glucose is elevated, insulin resistance has typically been present for years or decades. The pancreas has been pumping out higher and higher levels of insulin to keep the glucose number looking normal. Fasting glucose looks fine until the system cannot compensate anymore.
TSH behaves the same way. The pituitary keeps signaling the thyroid to produce T4. T4 levels look adequate. What neither test captures is what happens after — the conversion that doesn't happen, the receptor that gets blocked, the active hormone that never arrives at the cell.
The pattern across both systems
Thyroid: TSH measures the signal, not the conversion. T4 measures the storage hormone, not the active form. The failure lives in the gap between T4 and T3 — and that gap is invisible to standard labs. Metabolism: Fasting glucose measures fuel in circulation, not whether it is entering cells. High fasting insulin — which precedes glucose abnormality by years — is not part of the standard metabolic panel. The insulin resistance is present; the standard test cannot see it yet. What both miss: The mechanism, not the output. The conversion, not the supply. The patient is told both are normal — and is symptomatic in both — because the tests were designed to detect end-stage disease, not the functional failures that precede it.
For the insulin resistance parallel in full: Drug Library — search metformin for the insulin resistance mechanism
Reverse T3 — The Metabolic Brake
The deiodinase enzyme that converts T4 into active T3 has a second pathway. Under conditions the body interprets as starvation — low calories, low carbohydrate availability, extended fasting — the same enzyme is redirected to convert T4 into reverse T3 (rT3) instead.
Reverse T3 is a mirror-image molecule of T3. It is structurally almost identical. But it is biologically inert — it cannot activate the thyroid receptor. What it can do, and does, is occupy the T3 receptor, blocking active T3 from binding. The result is a body with adequate T4 in circulation, normal TSH, and thyroid receptors that are filled — but filled with a hormone that does nothing.
Why this was adaptive — and why it isn't now
In ancestral conditions, caloric restriction meant genuine famine. The body's response was biologically intelligent: downregulate metabolism to conserve energy, produce rT3 to block T3 receptors, slow every energy-intensive system until food became available again. This kept people alive through food scarcity. The problem is that the hypothalamus cannot distinguish between a genuine famine and a voluntary carbohydrate restriction protocol sold as a wellness intervention. The starvation signal is the same. The rT3 response is the same. And the woman doing carnivore for six months to "fix her metabolism" is getting the same metabolic suppression as someone who actually has no food.
Keto, Fasting, and the Hypothyroidism They Create
The clinical pattern is consistent. A woman starts keto or extended intermittent fasting. The first two to six weeks feel good — water loss from glycogen depletion, the novelty of ketone adaptation, sometimes genuine improvement in energy or clarity. Then the floor drops out. Fatigue returns worse than before. Hair starts falling. She is cold in rooms where no one else is cold. Weight loss stops completely, or reverses. Depression arrives. She cannot think clearly. The community tells her she needs to go stricter, give it more time, add more fat, try a longer fasting window. Every one of those recommendations deepens the starvation signal that is causing the problem.
The cycling trap
Keto protocols that cycle — strict low-carb phases followed by "carb-up" days — are promoted as a solution to the thyroid suppression problem. They do not resolve it. Cycling keeps the rT3 pool elevated between restriction phases. rT3 has a half-life of approximately 24–36 hours; the T3 receptor saturation from a week of strict keto does not clear in a single carb-up day. The thyroid axis is kept in a state of perpetual disruption rather than allowed to stabilize and fully recover. The rT3 pool clears when the starvation signal stops completely — not when it pauses briefly. Women whose BBT charts show persistently low baseline temperatures, delayed ovulation, shortened luteal phases, or flat post-ovulatory temperature rises are frequently showing the thermogenic signature of rT3 dominance from diet cycling. See: Fertility & Cycle Tracking — Tracking tab.
The dementia paradox — when keto for brain health creates the brain damage it claims to prevent
Ketogenic diets are actively promoted for Alzheimer's prevention and cognitive enhancement on the premise that ketones are a cleaner brain fuel than glucose when insulin resistance is present. The logic has a partial basis — ketones can bypass impaired glucose metabolism in certain neurons. What the promotion omits is the other side of the mechanism. Prolonged carbohydrate absence → insulin secretion capacity decreases. Pancreatic beta cells that are chronically underworked lose functional capacity. Insulin receptor sensitivity decreases with disuse. When carbohydrates are eventually reintroduced, the glucose management system is impaired — the keto diet has created or worsened the insulin resistance it was supposed to treat. Hippocampal neurons are glucose-dependent. Certain neurons — particularly in the hippocampus, which governs memory consolidation — cannot use ketones as a primary fuel. Prolonged glucose restriction to these neurons is not neutral. Emerging evidence suggests extreme long-term low-carbohydrate intake may accelerate hippocampal atrophy in susceptible individuals — not prevent it. The rT3 pathway compounds it. Low-carb → rT3 shunting → functional hypothyroidism → low T3 → impaired myelination → impaired neuronal energy production → cognitive decline. The dementia-like presentation that follows months of extreme low-carb is partly thyroid-driven — and it is being attributed to "keto adaptation" or "detox" rather than recognized as functional hypothyroidism compressing the neurological energy supply. The reintroduction crash is particularly damaging: coming off extreme long-term low-carb produces blood sugar dysregulation — glucose spikes and crashes — in a brain that has partially lost the metabolic machinery to manage glucose efficiently. This transition period can look like, and may contribute to, early dementia symptoms in people who were already cognitively vulnerable.
What the research actually supports: Moderate carbohydrate reduction — eliminating industrial fructose, refined starch, and seed oils while retaining whole-food carbohydrates (root vegetables, fruit, properly prepared grains) — addresses blood sugar dysregulation without generating the starvation signal that triggers rT3 shunting. This is not a pro-sugar argument. It is a distinction between industrial carbohydrate and real food carbohydrate. The body has a metabolic relationship with a sweet potato. It does not have one with high-fructose corn syrup. Removing both as "carbs" causes the harm. The target was always the industrial input — not the food.
Women's Thyroid Axis Is More Sensitive to Restriction
The research base for keto and intermittent fasting is built almost entirely on studies conducted in men. The female hypothalamic-pituitary axis is significantly more sensitive to caloric and carbohydrate restriction signals than the male equivalent. The same dietary approach that a man tolerates without measurable thyroid disruption can produce significant rT3 dominance in a woman within weeks to months.
Women already have higher baseline thyroid antibody rates, higher incidence of Hashimoto's thyroiditis, and higher inherent vulnerability to thyroid conversion disruption. Adding aggressive dietary restriction to a female endocrine system that is already managing cyclical hormonal demands — estrogen and progesterone cycles that themselves place demands on T3 availability — is adding a metabolic stressor to a system with less buffer than the male physiology that produced the dietary recommendations.
Cross-reference: diet culture and the protocols that harm women specifically
The full clinical picture of restriction-driven hormonal damage — HPA axis suppression, menstrual disruption, adrenal loading, and the protocols that produce this: Diet Culture Is Making You Sick — Diet Protocols tab
Liver
The liver is the organ that determines whether your thyroid hormone becomes the active form that runs your metabolism — or remains a storage molecule that circulates without function. More than 60% of all T3 in the body is produced not by the thyroid gland, but by the liver converting T4 in its own tissue. A damaged liver means a functionally hypothyroid body, regardless of what the thyroid gland is doing.
This connection is almost never discussed in thyroid medicine — partly because endocrinology and hepatology are separate specialties, and partly because the standard thyroid panel does not ask about liver function. The patient sees an endocrinologist for her thyroid and a gastroenterologist for her liver, and neither practitioner connects the two.
The Liver Does 60% of the Work
Non-Alcoholic Fatty Liver Disease (NAFLD)
NAFLD — now affecting an estimated 25–30% of the adult population in Western countries — impairs T4→T3 conversion through multiple mechanisms: reduced deiodinase enzyme activity in fatty liver tissue, increased inflammatory cytokine production (IL-6, TNF-α) that suppresses conversion, and impaired sulfation and glucuronidation of thyroid hormones. A person with NAFLD has both reduced capacity to convert T4 to T3 and an active inflammatory environment that further blocks conversion. NAFLD is primarily driven by high fructose intake and seed oil consumption — two industrial food inputs that the thyroid-hypothyroid conversation rarely connects to the thyroid story.
Medications That Impair Liver Conversion
Statins: inhibit the mevalonate pathway required for CoQ10 synthesis, reducing mitochondrial function in liver hepatocytes, which are the cells performing T4→T3 conversion. Acetaminophen (Tylenol): chronic use depletes glutathione — the liver's primary antioxidant required for phase II detoxification; glutathione depletion impairs hepatocyte function broadly, including conversion capacity. PPIs (omeprazole, pantoprazole): reduce stomach acid → impair protein and mineral absorption (selenium, iron, zinc) → deplete the cofactors deiodinase enzymes require. The person on a statin, a PPI, and acetaminophen for chronic pain — a common combination — has three simultaneous pharmaceutical assaults on T4→T3 conversion, none of which will appear on a thyroid panel.
Alcohol
Alcohol is directly hepatotoxic at doses well below those that produce diagnosed liver disease. Moderate regular alcohol use reduces hepatocyte efficiency — the liver cells performing T4→T3 conversion. Alcohol also directly suppresses TSH secretion, impairs iodine metabolism, and raises cortisol — which further inhibits conversion. "Moderate" drinking on top of an already compromised thyroid conversion system is not neutral. The woman told her drinking is "within guidelines" whose thyroid symptoms persist on thyroid medication may be suppressing her conversion with her wine.
The Estrogen Connection
The liver is responsible for clearing excess estrogen as well as converting thyroid hormone. An impaired or overburdened liver lets both functions suffer simultaneously. When the liver cannot efficiently process estrogen, estrogen levels rise — and elevated estrogen increases thyroid binding globulin (TBG), a protein that binds T4 and T3 in the bloodstream and makes them unavailable for conversion or cellular uptake. The result: higher circulating T4, lower free T4 available for conversion, lower free T3 available to cells. Estrogen dominance — from impaired liver clearance, environmental estrogens, or hormonal contraceptives — produces functional hypothyroidism through this mechanism. The thyroid panel shows elevated total T4. The patient feels hypothyroid. Both are true.
The Triple Hit — Keto + Statin + NAFLD
A person doing a ketogenic diet for metabolic health who also has NAFLD and is on a statin — a combination that is not uncommon — is simultaneously generating rT3 shunting from carbohydrate restriction, reducing hepatocyte conversion capacity from statin-induced mitochondrial impairment, and dealing with impaired deiodinase function from NAFLD-associated inflammation. Each of these is a partial hit to T4→T3 conversion. Together they can produce profound functional hypothyroidism with an entirely normal TSH, normal T4, and a statin prescription that was generated by the elevated cholesterol that hypothyroidism itself causes — because T3 drives LDL receptor activity and cholesterol clearance, and low T3 raises LDL.
Elevated Cholesterol as a Downstream Thyroid Symptom
T3 drives LDL receptor activity in the liver — the mechanism by which LDL cholesterol is cleared from the bloodstream. When T3 is low or functionally blocked by rT3, LDL receptor activity decreases, LDL clearance slows, and total and LDL cholesterol rise. This is a well-established mechanism in clinical hypothyroidism. What is less well-recognized is that it occurs in subclinical and functional hypothyroidism too — with normal TSH.
The clinical consequence: a person with rT3-driven functional hypothyroidism has elevated LDL. Their doctor orders a lipid panel. The statin is prescribed. The statin further impairs liver mitochondrial function, reducing T4→T3 conversion capacity. The elevated cholesterol — which was a symptom of the thyroid conversion failure — is now being treated with a drug that makes the underlying problem worse. The thyroid was never tested for conversion status. It will not be.
The downstream prescription cascade
Low T3 → elevated LDL → statin prescribed → statin impairs hepatocyte conversion → T3 falls further → depression worsens → SSRI prescribed → some SSRIs further impair thyroid function → fatigue and hair loss → iron panel ordered (shows low ferritin, which was contributing to the thyroid problem from the start) → iron prescribed without addressing absorption (which requires stomach acid, which is being suppressed by the PPI that was prescribed for the GI side effects of the SSRI). Every drug in this cascade is treating the downstream symptom of functional hypothyroidism. The thyroid conversion failure is never identified because it is never tested.
Symptoms
T3 is required for cellular energy production, serotonin synthesis, thermogenesis, gut motility, neuronal myelination, progesterone production, LDL clearance, hair follicle cycling, cardiac function, and bone metabolism. When T3 is functionally absent — because rT3 is occupying the receptor — every one of these systems runs below capacity simultaneously. The symptom picture is not random. It is the predictable biological consequence of cells that cannot produce energy.
Depression, SSRIs, and the T3 Connection
T3 is required for serotonin synthesis. It is required for serotonin receptor sensitivity. It is required for the neuronal energy production that allows the prefrontal cortex to regulate mood. A brain with low available T3 — whether from conversion failure, rT3 blocking, or frank hypothyroidism — produces less serotonin, responds less to what serotonin it does have, and cannot maintain the energy-intensive neurological activity that mood regulation requires.
The result is a depression that is biologically indistinguishable from primary depressive disorder in presentation — fatigue, low mood, cognitive slowing, loss of interest, disrupted sleep. An SSRI is prescribed. SSRIs act on serotonin reuptake — but if the upstream problem is T3 deficiency, there is not enough serotonin in the system for the SSRI to work with. The antidepressant will have partial or no effect. The dose is increased. Additional agents are added. The thyroid conversion failure is not tested.
What some antidepressants do to thyroid function
Several antidepressants and psychiatric medications directly impair thyroid function. Lithium blocks thyroid hormone release. Paroxetine (Paxil) inhibits CYP2D6 — an enzyme involved in thyroid hormone metabolism. Sertraline has been associated with reduced free T4 in some studies. Tricyclic antidepressants can increase thyroid binding globulin, reducing free hormone availability. The patient prescribed an antidepressant for a T3-deficiency depression may be receiving a medication that makes the underlying thyroid problem worse. See the Drug Library for individual drug-thyroid interactions.
Infertility, Miscarriage, and Low T3
T3 is required for progesterone production. The corpus luteum — the structure that forms after ovulation and produces the progesterone that maintains the uterine lining for implantation — is T3-dependent. Low T3 produces a functionally deficient corpus luteum: insufficient progesterone, a shortened luteal phase, and a uterine environment that cannot support early implantation.
T3 is also required for LH pulsatility — the rhythm of the signal that triggers ovulation. Hypothyroid states suppress LH pulse frequency and amplitude, producing irregular or absent ovulation. The woman being worked up for unexplained infertility, with normal TSH and a recommendation for fertility drugs, may have functional hypothyroidism from rT3 dominance that no one has tested.
The diet-infertility connection
Women doing low-carb or intermittent fasting protocols while trying to conceive — often advised as "anti-inflammatory" or "blood sugar balancing" for fertility — may be generating rT3 dominance that is directly suppressing the progesterone and LH function their fertility depends on. The BBT chart shows this clearly when it is read correctly: low baseline temperatures, delayed ovulation, a short luteal phase, and a flat or inadequate post-ovulatory temperature rise. See: Fertility & Cycle Tracking
The Panel That Actually Shows Conversion Status
A standard thyroid panel — TSH, sometimes free T4 — cannot detect rT3 dominance, conversion failure, or functional hypothyroidism. The tests that show what is actually happening require requesting each component specifically. Most practitioners will not order them without prompting, because they are not part of standard thyroid screening protocols.
The ratio that matters most
Free T3 ÷ Reverse T3 (using ng/dL for both) should be above 20. A result of 15 means the receptor blocking problem is significant. A result of 10 or below means functional hypothyroidism is severe — and this can coexist with a completely normal TSH, normal T4, and a practitioner who is confident your thyroid is fine.
Basal Body Temperature as a Thyroid Proxy
Before modern thyroid testing existed, basal body temperature (BBT) was the primary diagnostic tool for hypothyroidism — developed by Dr. Broda Barnes, who correlated low waking temperature with hypothyroid symptoms with remarkable clinical accuracy. It remains one of the most accessible self-assessment tools available.
Glass or digital thermometer, taken immediately on waking before getting out of bed or speaking. Place under the arm for 10 minutes. Record daily for at least 5–7 consecutive days. Menstruating women: most informative during the first 5 days of the cycle (day 1–5), before ovulation raises temperature.
97.8–98.2°F (36.6–36.8°C): optimal range for thyroid function. Consistently below 97.6°F: suggestive of functional hypothyroidism. Consistently below 97.0°F: significant thyroid suppression indicated. Variable — swinging 1°F or more day to day: adrenal involvement, cortisol dysregulation, or both.
What the BBT chart shows that blood tests don't
A consistently low BBT baseline in a woman with normal TSH is strong clinical evidence of functional T3 deficiency — the cells cannot generate heat because they cannot generate energy, because T3 is not activating the mitochondria that do both. A delayed ovulatory temperature rise or a short luteal phase adds the reproductive layer — low T3 is suppressing the progesterone production that was supposed to follow ovulation. This is visible on the chart before any blood test orders it confirmed.
BBT charting methodology and fertility cycle interpretation: Fertility & Cycle Tracking
Recovery — Clearing the rT3 Pool and Restoring Conversion
rT3 has a biological half-life of approximately 24–36 hours. The rT3 pool can clear within days once the triggers are removed — but the triggers must actually stop, not just pause. The recovery protocol is not complex. It requires removing the starvation signal, supporting the conversion machinery, and reducing the cortisol and inflammatory drivers that are suppressing the pathway.
Restore carbohydrate signaling
Some carbohydrate is required for T4→T3 conversion. This is not permission to eat industrial food. It is a physiology argument for real food carbohydrates: root vegetables (sweet potato, potato, cassava, beets), fruit, white rice, properly prepared grains. The goal is adequate glucose availability to signal the deiodinase system that famine conditions have ended. This does not require high-carbohydrate eating — it requires not eliminating carbohydrate entirely.
Selenium — deiodinase cofactor
1–2 Brazil nuts per day provides the selenium deiodinase enzymes require. Wild-caught fish (sardines, salmon, tuna), pastured eggs, and organ meats are additional reliable sources. Selenium supplementation at high doses (above 400 mcg/day) becomes toxic — food sources are the safer delivery mechanism and are self-limiting by satiety.
Iron — ferritin optimization
Thyroid peroxidase is an iron-dependent enzyme. Low ferritin — even within the lab "normal" range — impairs thyroid hormone synthesis at the source. The threshold that matters clinically is ferritin above 70 ng/mL, not just above the lab floor of 12. Dietary iron from heme sources (liver, red meat, clams, oysters) absorbs at 15–35% efficiency versus 2–20% for plant sources. Women with hair loss and fatigue alongside low ferritin should address iron through food before supplementation — iron supplements in the wrong form (ferrous sulfate) cause GI disruption and oxidative stress that can worsen inflammation and further suppress conversion.
Reduce cortisol drivers
Cortisol directly inhibits T4→T3 conversion and promotes rT3 production. The cortisol reduction list is the thyroid recovery list: sleep (growth hormone and cortisol regulation both occur during deep sleep), blood sugar stability (glucose swings activate the cortisol stress response), EMF reduction (non-native EMF elevates cortisol and activates the HPA axis), nervous system support (parasympathetic activation — real meals at a table, social connection, outdoor time — reduces the cortisol burden on the conversion pathway).
Support liver conversion capacity
Bitter foods (dandelion greens, arugula, chicory) stimulate bile production and liver detoxification. Beets support phase II liver conjugation. Adequate protein is required for phase II detoxification enzymes (glucuronidation, sulfation) that process thyroid hormones. Reducing pharmaceutical load where clinically possible — specifically statins, PPIs, and acetaminophen — removes direct impairments to hepatocyte conversion capacity. This is not a unilateral medication change — it is a conversation with the prescriber about what the medications are doing to the conversion mechanism.
Reduce inflammation
The cytokine cascade (IL-1, IL-6, TNF-α) suppresses deiodinase activity directly. Inflammation drivers that can be addressed: industrial seed oils (oxidized polyunsaturated fats are the primary driver of IL-6 and TNF-α in the food supply), high fructose intake (drives NAFLD and hepatic inflammation), gut dysbiosis (produce lipopolysaccharide — LPS — a potent inflammatory signal), and EMF exposure (activates VGCC-driven inflammatory signaling). None of these are addressed by thyroid medication.
What to ask your practitioner: "Can we add free T3, reverse T3, TPO antibodies, TgAb, and ferritin to my next thyroid panel?" Most practitioners who understand the rationale will order them. Those who won't will often relent if you bring the request in writing with a brief explanation that you want to assess conversion, not just gland output. If your practitioner dismisses the request entirely, the conversation about what your thyroid is actually doing has not yet been had — and the information you need is available through direct-access labs (Ulta Lab Tests, Walk-In Lab) without a practitioner order in most US states.
Where This Connects
Fertility & Cycle Tracking — BBT as a thyroid proxy, rT3 signature on the chart, ovulatory and luteal phase patterns from functional hypothyroidism
Diet Culture Is Making You Sick — the full clinical picture of restriction protocols, keto, fasting, and the hormonal damage they produce in women
GLP-1 Drugs — What You're Not Being Told — starvation physiology, lean mass loss, and rT3 shunting from appetite suppression drugs
Drug Library — individual drug-thyroid interactions: statins, SSRIs, lithium, PPIs, corticosteroids, and the downstream prescription cascade from untreated conversion failure
Ready to go deeper?
Fellowship opens the door to personal ministry support from Rev. Allie — applied to your specific path.
Enter into Fellowship